Interleukin-3, interleukin-5, and granulocyte-macrophage colony-stimulating factor expression in nasal polyps
- 1 July 1997
- journal article
- Published by Elsevier in American Journal of Otolaryngology
- Vol. 18 (4) , 239-246
- https://doi.org/10.1016/s0196-0709(97)90003-x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Comparison of the role of nasal polyp and normal nasal mucosal epithelial cells on in vitro eosinophil survival. Mediation by GM–CSF and inhibition by dexamethasoneClinical and Experimental Allergy, 1994
- T cells and eosinophils in the pathogenesis of asthmaImmunology Today, 1992
- Cytokine regulation of eosinophil functionClinical Immunology and Immunopathology, 1992
- GM-CSF, IL-3 and IL-5: cross-competition on human haemopoietic cellsImmunology Today, 1992
- The Immunobiology of EosinophilsNew England Journal of Medicine, 1991
- Nasal polyposisJournal of Allergy and Clinical Immunology, 1990
- The eosinophil and bronchial asthma: Current understandingJournal of Allergy and Clinical Immunology, 1990
- Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3.Journal of Clinical Investigation, 1988
- Recombinant human interleukin 5 is a selective activator of human eosinophil function.The Journal of Experimental Medicine, 1988
- 187. Clinical characteristics and therapy of nasal polypsJournal of Allergy and Clinical Immunology, 1978